Crossing the Species Barrier: Developing Humanized Rodent Models to Optimize Transability into the Clinic

Time: 9:00 am
day: Day Two


• Developing a rodent model with xenotransplanted human cells to investigate neuroimmunology targets of interest

• Assessing chimeric cell functionality in model development

• Utilizing humanized rodent models to identify the contribution of human microglia to neurodegenerative disease pathogenesis and advance microglia as a therapeutic target